BioNTech Faces Shareholder Investigation Amid Losses and Founder Exodus
Law firm investigates $BNTX following €305M Q4 loss, plunging COVID vaccine demand, and planned founder departure, examining potential securities law violations.
BNTXfederal securities lawssecurities fraud investigation
